Announcement
06 Nov 2020
On 7 November 2020, the UK authorities added dabigatran etexilate and semaglutide to the medicines that cannot be parallel exported from the UK.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
07 Nov 2020
Revocation date:
23 Jun 2022
Updated: 06 Nov 2020
Export ban
On 7 November 2020, the Department of Health and Social Care of the United Kingdom added dabigatran etexilate and semaglutide to the medicines that cannot be parallel exported from the UK.
...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.